Health Canada's consultation on new additions to the Pathogens of Interest List
From Health Canada
Current status: Open
Opened on November 18, 2020 and will close on January 4, 2021.
The purpose of this consultation is to request feedback from the public and stakeholders regarding the inclusion of additional antimicrobial resistant pathogens to the updated Pathogens of Interest List (the List). Pathogens on the List are deemed as pathogens creating the most urgent need for therapeutic drugs and/or diagnostic devices in Canada.
Join in: how to participate
Send an email to the Bureau of Gastroenterology, Infection, and Viral Diseases (BGIVD) at email@example.com with your comments or suggestions.
Who is the focus of this consultation
This consultation is intended for:
- Pharmaceutical and diagnostic developers
- Medical professionals and academics
- Patient advocacy groups
Comments are also welcome from all other interested stakeholders and members of the general public.
Key questions for discussion
To foster the development of innovative human therapeutic products to combat antimicrobial resistance (AMR), Health Canada has several regulatory measures that are available to expedite the review and approval process for drugs and diagnostic devices targeting pathogens on the List. Health Canada has updated the List to include fungal pathogens specific to the Canadian context.
Your comments and suggestions are sought around the proposed update to the List, as well as on regulatory approaches to facilitate industry development for drugs and diagnostics targeting AMR pathogens:
- Should any of the proposed additional pathogens be removed from the update List and why?
- Should any other pathogens be added to the updated List and why?
- What new regulatory approaches or policy tools could be adopted that would facilitate greater access to safe, effective and high quality therapies to help address the AMR issue?
The input gathered through the consultation will be incorporated into the decision-making process of updating the List.
Bureau of Gastroenterology Infection and Viral Diseases
Therapeutic Products Directorate
Health Products and Food Branch
Address Locator: 0202B
Report a problem or mistake on this page
- Date modified: